Literature DB >> 26924380

MutT Homolog 1 (MTH1): The Silencing of a Target.

Gianluca Papeo1.   

Abstract

MTH1 is a member of the nudix phosphohydrolase superfamily of enzymes, and it is involved in nucleotide pool homeostasis. The protein exerts its scavenging action by hydrolyzing oxidized nucleotides, thus avoiding their misincorporation into replicating DNA. Recent reports have validated its inhibition as a potential broad-spectrum target in oncology and have described small molecules able to engage this target with antiproliferative effect. In the accompanying paper (DOI: 10.1021/acs.jmedchem.5b01760 ), a team at AstraZeneca led by Jason G. Kettle elegantly demonstrated the complete lack of antiproliferative activity of cancer cells to highly potent MTH1 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26924380     DOI: 10.1021/acs.jmedchem.6b00283

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  1H-Pyrazolo[3,4-b]quinolines: Synthesis and Properties over 100 Years of Research.

Authors:  Andrzej Danel; Ewa Gondek; Mateusz Kucharek; Paweł Szlachcic; Arkadiusz Gut
Journal:  Molecules       Date:  2022-04-26       Impact factor: 4.927

2.  Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation.

Authors:  Julie Farand; Jeffrey E Kropf; Peter Blomgren; Jianjun Xu; Aaron C Schmitt; Zachary E Newby; Ting Wang; Eisuke Murakami; Ona Barauskas; Jawahar Sudhamsu; Joy Y Feng; Anita Niedziela-Majka; Brian E Schultz; Karen Schwartz; Serge Viatchenko-Karpinski; Dmytro Kornyeyev; Adam Kashishian; Peidong Fan; Xiaowu Chen; Eric B Lansdon; Michael O Ports; Kevin S Currie; William J Watkins; Gregory T Notte
Journal:  ACS Med Chem Lett       Date:  2019-11-19       Impact factor: 4.345

3.  MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?

Authors:  Hussein H K Abbas; Kheloud M H Alhamoudi; Mark D Evans; George D D Jones; Steven S Foster
Journal:  BMC Cancer       Date:  2018-04-16       Impact factor: 4.430

4.  Potent and specific MTH1 inhibitors targeting gastric cancer.

Authors:  Wenjuan Zhou; Liying Ma; Jing Yang; Hui Qiao; Lingyu Li; Qian Guo; Jinlian Ma; Lijuan Zhao; Junwei Wang; Guozhong Jiang; Xiangbin Wan; Mariusz Adam Goscinski; Lina Ding; Yichao Zheng; Wencai Li; Hongmin Liu; Zhenhe Suo; Wen Zhao
Journal:  Cell Death Dis       Date:  2019-06-04       Impact factor: 8.469

Review 5.  Targeting human MutT homolog 1 (MTH1) for cancer eradication: current progress and perspectives.

Authors:  Yizhen Yin; Fener Chen
Journal:  Acta Pharm Sin B       Date:  2020-03-30       Impact factor: 11.413

6.  HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress.

Authors:  Jian Shi; Zhiyong Xiong; Keshan Wang; Changfei Yuan; Yu Huang; Wen Xiao; Xiangui Meng; Zhixian Chen; Qingyang Lv; Daojia Miao; Huageng Liang; Tianbo Xu; Kairu Xie; Hongmei Yang; Xiaoping Zhang
Journal:  Clin Transl Med       Date:  2021-11

7.  (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1.

Authors:  Xuanxuan Dai; Guilong Guo; Peng Zou; Ri Cui; Weiqian Chen; Xi Chen; Changtian Yin; Wei He; Rajamanickam Vinothkumar; Fan Yang; Xiaohua Zhang; Guang Liang
Journal:  J Exp Clin Cancer Res       Date:  2017-09-07

Review 8.  Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.

Authors:  Pierpaola Davalli; Gaetano Marverti; Angela Lauriola; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.